Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis
Claudia Scholl, … , D. Gary Gilliland, Stefan Fröhling
Claudia Scholl, … , D. Gary Gilliland, Stefan Fröhling
Published April 2, 2007
Citation Information: J Clin Invest. 2007;117(4):1037-1048. https://doi.org/10.1172/JCI30182.
View: Text | PDF
Research Article Article has an altmetric score of 12

The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis

  • Text
  • PDF
Abstract

The homeobox transcription factor CDX2 plays an important role in embryonic development and regulates the proliferation and differentiation of intestinal epithelial cells in the adult. We have found that CDX2 is expressed in leukemic cells of 90% of patients with acute myeloid leukemia (AML) but not in hematopoietic stem and progenitor cells derived from normal individuals. Stable knockdown of CDX2 expression by RNA interference inhibited the proliferation of various human AML cell lines and strongly reduced their clonogenic potential in vitro. Primary murine hematopoietic progenitor cells transduced with Cdx2 acquired serial replating activity, were able to be continuously propagated in liquid culture, generated fully penetrant and transplantable AML in BM transplant recipients, and displayed dysregulated expression of Hox family members in vitro and in vivo. These results demonstrate that aberrant expression of the developmental regulatory gene CDX2 in the adult hematopoietic compartment is a frequent event in the pathogenesis of AML; suggest a role for CDX2 as part of a common effector pathway that promotes the proliferative capacity and self-renewal potential of myeloid progenitor cells; and support the hypothesis that CDX2 is responsible, in part, for the altered HOX gene expression that is observed in most cases of AML.

Authors

Claudia Scholl, Dimple Bansal, Konstanze Döhner, Karina Eiwen, Brian J.P. Huntly, Benjamin H. Lee, Frank G. Rücker, Richard F. Schlenk, Lars Bullinger, Hartmut Döhner, D. Gary Gilliland, Stefan Fröhling

×

Total citations by year

Year: 2024 2022 2021 2020 2019 2018 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 3 2 4 3 5 1 2 3 6 5 7 4 6 5 3 2 61
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (61)

Title and authors Publication Year
Regulation of HOX gene expression in AML.
Khan I, Amin MA, Eklund EA, Gartel AL
Blood Cancer Journal 2024
Aberrant stem cell and developmental programs in pediatric leukemia
Ling RE, Cross JW, Roy A
Frontiers in Cell and Developmental Biology 2024
miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers
Cheng YC, Fan Z, Liang C, Peng CJ, Li Y, Wang LN, Luo JS, Zhang XL, Liu Y, Zhang LD
Technology in cancer research & treatment 2024
UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
Bastian L, Hartmann AM, Beder T, Hänzelmann S, Kässens J, Bultmann M, Hoeppner MP, Franzenburg S, Wittig M, Franke A, Nagel I, Spielmann M, Reimer N, Busch H, Schwartz S, Steffen B, Viardot A, Döhner K, Kondakci M, Wulf G, Wendelin K, Renzelmann A, Kiani A, Trautmann H, Neumann M, Gökbuget N, Brüggemann M, Baldus CD
Leukemia 2022
Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL
Passet M, Kim R, Gachet S, Sigaux F, Chaumeil J, Galland A, Sexton T, Quentin S, Hernandez L, Larcher L, Bergugnat H, Ye T, Karasu N, Caye A, Heizmann B, Duluc I, Chevallier P, Rousselot P, Huguet F, Leguay T, Hunault M, Pflumio F, Freund JN, Lobry C, Lhéritier V, Dombret H, Domon-Dell C, Soulier J, Boissel N, Clappier E
Blood 2022
The Cross Marks the Spot: The Emerging Role of JmjC Domain-Containing Proteins in Myeloid Malignancies
HF Staehle, HL Pahl, JS Jutzi
Biomolecules 2021
CDX2 expression in the hematopoietic lineage promotes leukemogenesis via TGFβ inhibition
A Galland, V Gourain, K Habbas, Y Güler, E Martin, C Ebel, M Tavian, L Vallat, MP Chenard, L Mauvieux, JN Freund, I Duluc, C DomonDell
Molecular Oncology 2021
CDX2 regulates ACE expression in blood development and leukemia cells
RE Omar, E Julien, K Biasch, B Guffroy, B Lioure, L Vallat, I Gross, C Domon-Dell, F Lanza, C Gachet, M Negroni, JN Freund, M Tavian
Blood Advances 2021
A Core Response to the CDX2 Homeoprotein During Development and in Pathologies
V Gourain, I Duluc, C Domon-Dell, JN Freund
Frontiers in Genetics 2021
The role of transcription factor caudal-related homeobox transcription factor 2 in colorectal cancer
CC Wu, TW Hsu, CC Yeh, HB Huang
Tzu Chi Medical Journal 2020
Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia
T Vu, J Straube, AH Porter, M Bywater, A Song, V Ling, L Cooper, G Pali, C Bruedigam, S Jacquelin, J Green, G Magor, A Perkins, AM Chalk, CR Walkley, FH Heidel, P Mukhopadhyay, N Cloonan, S Gröschel, JP Mallm, S Fröhling, C Scholl, SW Lane
Nature Communications 2020
Identification of Genes Whose Expression Overlaps Age Boundaries and Correlates with Risk Groups in Paediatric and Adult Acute Myeloid Leukaemia
L Davis, KI Mills, KH Orchard, BA Guinn
Cancers 2020
Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia
S Saha, KC Murmu, M Biswas, S Chakraborty, J Basu, S Madhulika, SP Kolapalli, S Chauhan, A Sengupta, P Prasad
Frontiers in Oncology 2019
Cdx2 Animal Models Reveal Developmental Origins of Cancers
K Chawengsaksophak
Genes & development 2019
Neogenin-1 distinguishes between myeloid-biased and balanced Hoxb5 + mouse long-term hematopoietic stem cells
GS Gulati, M Zukowska, JJ Noh, A Zhang, DJ Wesche, R Sinha, BM George, IL Weissman, K Szade
Proceedings of the National Academy of Sciences 2019
The microRNA miR-196b acts as a tumor suppressor in Cdx2-driven acute myeloid leukemia
VP Rawat, M Götze, A Rasalkar, NM Vegi, S Ihme, S Thoene, A Pastore, D Bararia, H Döhner, K Döhner, M Feuring-Buske, L Quintanilla-Fend, C Buske
Haematologica 2019
Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia
JL Jafek, A Shakya, PY Tai, A Ibarra, H Kim, J Maddox, J Chumley, GJ Spangrude, RR Miles, TW Kelley, D Tantin
Experimental Hematology 2019
The impact of Mir-9 regulation in normal and malignant hematopoiesis
A Khosravi, S Alizadeh, A Jalili, R Shirzad, N Saki
Oncology Reviews 2018
Acute myeloid leukemia requires Hhex to enable PRC2-mediated epigenetic repression of Cdkn2a
BJ Shields, JT Jackson, D Metcalf, W Shi, Q Huang, AL Garnham, SP Glaser, D Beck, JE Pimanda, CW Bogue, GK Smyth, WS Alexander, MP McCormack
Genes & development 2016
[Bioinformatics analysis of microRNA comprehensive regulatory network in B- cell acute lymphoblastic leukemia]
M N Zeng, W L Ma, W L Zheng
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2016
Extending the functions of the homeotic transcription factor Cdx2 in the digestive system through nontranscriptional activities
JN Freund
World journal of gastroenterology : WJG 2015
Survival regulation of leukemia stem cells
Y Hu, S Li
Cellular and Molecular Life Sciences 2015
Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation
Kapoor I, Kanaujiya J, Kumar Y, Thota JR, Bhatt ML, Chattopadhyay N, Sanyal S, Trivedi AK
Oncotarget 2015
Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia
BE Li, P Ernst
Experimental Hematology 2014
C/EBP  is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis
C Collins, J Wang, H Miao, J Bronstein, H Nawer, T Xu, M Figueroa, AG Muntean, JL Hess
Proceedings of the National Academy of Sciences 2014
Prediction and identification of HLA-A*0201-restricted epitopes from leukemia-associated protein MLAA-22 which elicit cytotoxic T lymphocytes
J Li, J Bai, L Gu, A He, J Wang, J Wang, P Zhang, W Zhang
Medical Oncology 2014
Telomerase Inhibition Effectively Targets Mouse and Human AML Stem Cells and Delays Relapse following Chemotherapy
C Bruedigam, FO Bagger, FH Heidel, C Paine Kuhn, S Guignes, A Song, R Austin, T Vu, E Lee, S Riyat, AS Moore, RB Lock, L Bullinger, GR Hill, SA Armstrong, DA Williams, SW Lane
Cell Stem Cell 2014
Transcriptional Regulation of the Intestinal Nuclear Bile Acid Farnesoid X Receptor (FXR) by the caudal-related Homeobox 2 (CDX2)
S Modica, M Cariello, A Morgano, I Gross, MC Vegliante, S Murzilli, L Salvatore, JN Freund, C Sabba, A Moschetta
The Journal of biological chemistry 2014
A role for BMP-induced homeobox gene MIXL1 in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapy
Raymond A, Liu B, Liang H, Wei C, Guindani M, Lu Y, Liang S, St. John LS, Molldrem J, Nagarajan L
Oncotarget 2014
Targeting self-renewal pathways in myeloid malignancies
WA Sands, M Copland, H Wheadon
Cell Communication and Signaling 2013
Among Sinonasal Tumors, CDX-2 Immunoexpression is not Restricted to Intestinal-Type Adenocarcinomas
MP Tilson, GL Gallia, JA Bishop
Head and Neck Pathology 2013
Hoxb8 regulates expression of microRNAs to control cell death and differentiation
M Salmanidis, G Brumatti, N Narayan, BD Green, JA van Bergen, JJ Sandow, AG Bert, N Silke, R Sladic, H Puthalakath, L Rohrbeck, T Okamoto, P Bouillet, MJ Herold, GJ Goodall, AM Jabbour, PG Ekert
Cell Death and Differentiation 2013
A Cdx4-Sall4 Regulatory Module Controls the Transition from Mesoderm Formation to Embryonic Hematopoiesis
EJ Paik, S Mahony, RM White, EN Price, A DiBiase, B Dorjsuren, C Mosimann, AJ Davidson, D Gifford, LI Zon
Stem Cell Reports 2013
Deregulation of the CDX2-KLF4 axis in acute myeloid leukemia and colon cancer
Rouhi A, Fröhling S
Oncotarget 2013
Leukemogenesis by CDX2 involves KLF4 repression and deregulated PPARγ signaling
Katrin Faber, Lars Bullinger, Christine Ragu, Angela Garding, Daniel Mertens, Christina Miller, Daniela Martin, Daniel Walcher, Konstanze Döhner, Hartmut Döhner, Rainer Claus, Christoph Plass, Stephen Sykes, Steven Lane, Claudia Scholl, Stefan Fröhling
Journal of Clinical Investigation 2012
Beyond Hox: the role of ParaHox genes in normal and malignant hematopoiesis
VP Rawat, RK Humphries, C Buske
Blood 2012
H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia
M Kawahara, A Pandolfi, B Bartholdy, L Barreyro, B Will, M Roth, UC Okoye-Okafor, TI Todorova, ME Figueroa, A Melnick, CS Mitsiades, U Steidl
Cancer Cell 2012
Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma
KB Nyquist, I Panagopoulos, J Thorsen, L Haugom, L Gorunova, B Bjerkehagen, A Fosså, M Guriby, T Nome, RA Lothe, RI Skotheim, S Heim, F Micci
PloS one 2012
Widespread over-expression of the non-clustered homeobox gene HLX in acute myeloid leukemia
S Fröhling
Haematologica 2012
Caudal genes in blood development and leukemia
C Lengerke, GQ Daley
Annals of the New York Academy of Sciences 2012
HLX in AML: novel prognostic and therapeutic target
Pandolfi A, Steidl U
Oncotarget 2012
Modulation of Tcf3 repressor complex composition regulates cdx4 expression in zebrafish
H Ro, IB Dawid
The EMBO Journal 2011
Identification and characterization of Hoxa9 binding sites in hematopoietic cells
Y Huang, K Sitwala, J Bronstein, D Sanders, M Dandekar, C Collins, G Robertson, J MacDonald, T Cezard, M Bilenky, N Thiessen, Y Zhao, T Zeng, M Hirst, A Hero, S Jones, JL Hess
Blood 2011
Cdx2 homeoprotein inhibits non-homologous end joining in colon cancer but not in leukemia cells
B Renouf, C Soret, T Saandi, F Delalande, E Martin, M Vanier, I Duluc, I Gross, JN Freund, C Domon-Dell
Nucleic Acids Research 2011
miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies
KY Lin, XJ Zhang, DD Feng, H Zhang, CW Zeng, BW Han, AD Zhou, LH Qu, L Xu, YQ Chen
The Journal of biological chemistry 2011
Cdx4 is dispensable for murine adult hematopoietic stem cells but promotes MLL-AF9-mediated leukemogenesis
S Koo, BJ Huntly, Y Wang, J Chen, K Brumme, B Ball, SL McKinney-Freeman, A Yabuuchi, C Scholl, D Bansal, LI Zon, S Fröhling, GQ Daley, DG Gilliland, T Mercher
Haematologica 2010
The vent-like homeobox gene VENTX promotes human myeloid differentiation and is highly expressed in acute myeloid leukemia
VP Rawat, N Arseni, F Ahmed, MA Mulaw, S Thoene, B Heilmeier, T Sadlon, RJ D'Andrea, W Hiddemann, SK Bohlander, C Buske, M Feuring-Buske
Proceedings of the National Academy of Sciences 2010
TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis-regulatory regions
MP Verzi, P Hatzis, R Sulahian, J Philips, J Schuijers, H Shin, E Freed, JP Lynch, DT Dang, M Brown, H Clevers, XS Liu, RA Shivdasani
Proceedings of the National Academy of Sciences 2010
GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis
Z Wang, M Iwasaki, F Ficara, C Lin, C Matheny, SH Wong, KS Smith, ML Cleary
Cancer Cell 2010
Autologous blood cell therapies from pluripotent stem cells
C Lengerke, GQ Daley
Blood Reviews 2010
Oct1 Is a Switchable, Bipotential Stabilizer of Repressed and Inducible Transcriptional States*
A Shakya, J Kang, J Chumley, MA Williams, D Tantin
The Journal of biological chemistry 2010
Transmission and expansion of HOXB4-induced leukemia in two immunosuppressed dogs: Implications for a new canine leukemia model
MS Thakar, XB Zhang, BC Beard, GE Sale, EB Santos, L Peterson, HP Kiem, BM Sandmaier
Experimental Hematology 2009
Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis
I Hofmann, EH Stover, DE Cullen, J Mao, KJ Morgan, BH Lee, MG Kharas, PG Miller, MG Cornejo, R Okabe, SA Armstrong, N Ghilardi, S Gould, FJ de Sauvage, AP McMahon, DG Gilliland
Cell Stem Cell 2009
Acute myeloid leukemia stem cells: seek and destroy
GJ Roboz, M Guzman
Expert Review of Hematology 2009
Human BRE1 Is an E3 Ubiquitin Ligase for Ebp1 Tumor Suppressor
Z Liu, SM Oh, M Okada, X Liu, D Cheng, J Peng, DJ Brat, S Sun, W Zhou, W Gu, K Ye, J Chernoff
Molecular biology of the cell 2009
Cytosolic acetyl‐CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl‐CoA/acetate metabolism
Yoshii Y, Furukawa T, Yoshii H, Mori T, Kiyono Y, Waki A, Kobayashi M, Tsujikawa T, Kudo T, Okazawa H, Yonekura Y, Fujibayashi Y
Cancer Science 2009
High-affinity neurotrophin receptors and ligands promote leukemogenesis
Z Li, G Beutel, M Rhein, J Meyer, C Koenecke, T Neumann, M Yang, J Krauter, N Neuhoff, M Heuser, H Diedrich, G Göhring, L Wilkens, B Schlegelberger, A Ganser, C Baum
Blood 2008
Modulation of murine embryonic stem cell-derived CD41+c-kit+ hematopoietic progenitors by ectopic expression of Cdx genes
SL McKinney-Freeman, C Lengerke, IH Jang, S Schmitt, Y Wang, M Philitas, J Shea, GQ Daley
Blood 2008
Acute Myeloid Leukemia with a Complex Karyotype
K Mrózek
Seminars in Oncology 2008
HOX deregulation in acute myeloid leukemia
Kim L. Rice and Jonathan D. Licht
Journal of Clinical Investigation 2007
The preleukemic state of mice reconstituted with Mixl1-transduced marrow cells
D Metcalf, S Glaser, S Mifsud, LD Rago, L Robb
Proceedings of the National Academy of Sciences 2007

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 5 patents
Referenced in 1 Wikipedia pages
93 readers on Mendeley
1 readers on CiteULike
See more details